Variant report
Variant | nsv516231 |
---|---|
Chromosome Location | chr16:74873513-74875946 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:10)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:10 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr16:74875936-74876280 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr16:74874704-74874904 | HepG2 | liver: | n/a | chr16:74874833-74874844 |
3 | CEBPB | chr16:74873527-74873554 | A549 | lung: | n/a | n/a |
4 | CEBPB | chr16:74874804-74874902 | K562 | blood: | n/a | chr16:74874833-74874844 |
5 | CTCF | chr16:74874761-74874827 | GM10248 | blood: | n/a | n/a |
6 | POLR2A | chr16:74874227-74874339 | ProgFib | skin: | n/a | n/a |
7 | SPI1 | chr16:74874336-74874508 | K562 | blood: | n/a | n/a |
8 | SPI1 | chr16:74874311-74874565 | K562 | blood: | n/a | n/a |
9 | SPI1 | chr16:74874359-74874598 | HL-60 | blood: | n/a | n/a |
10 | SPI1 | chr16:74874360-74874578 | GM12878 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:74859894..74862181-chr16:74872505..74874523,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000261458 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs725710 | chr16:74873513-74873514 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs547054822 | chr16:74873527-74873528 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs370568664 | chr16:74873528-74873529 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs725709 | chr16:74873574-74873575 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs150462157 | chr16:74873583-74873584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555886261 | chr16:74873600-74873601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138421243 | chr16:74873624-74873625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs183475539 | chr16:74873627-74873628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186616492 | chr16:74873654-74873655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs572238948 | chr16:74873678-74873679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533284038 | chr16:74873686-74873687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541241310 | chr16:74873698-74873699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs148847991 | chr16:74873709-74873710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs143522057 | chr16:74873747-74873748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs137871222 | chr16:74873759-74873760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563523002 | chr16:74873773-74873774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529291904 | chr16:74873820-74873821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192736501 | chr16:74873850-74873851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs929883 | chr16:74873867-74873868 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs929882 | chr16:74873913-74873914 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs551540951 | chr16:74873924-74873925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs7190905 | chr16:74873927-74873928 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs532878126 | chr16:74873928-74873929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142387511 | chr16:74873934-74873935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs569501380 | chr16:74873966-74873967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs202116795 | chr16:74873967-74873968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs377541542 | chr16:74874070-74874071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs555663373 | chr16:74874076-74874077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs112272677 | chr16:74874077-74874078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs58075393 | chr16:74874078-74874079 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs7191282 | chr16:74874079-74874080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs534944310 | chr16:74874081-74874082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs113958720 | chr16:74874116-74874117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs71378711 | chr16:74874125-74874126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs35903582 | chr16:74874128-74874129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs59459547 | chr16:74874146-74874147 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs543510736 | chr16:74874159-74874160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs141693151 | chr16:74874270-74874271 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs12923955 | chr16:74874293-74874294 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs573665552 | chr16:74874329-74874330 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs150774791 | chr16:74874348-74874349 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs188251939 | chr16:74874361-74874362 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs545726412 | chr16:74874377-74874378 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs546200016 | chr16:74874431-74874432 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs531139219 | chr16:74874492-74874493 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs9925233 | chr16:74874522-74874523 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs563408838 | chr16:74874546-74874547 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs8048847 | chr16:74874621-74874622 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs370450592 | chr16:74874640-74874641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs558436132 | chr16:74874684-74874685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21806811 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 19156837 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Breast cancer | 20409316 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Epilepsy | 20502679 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:74864800-74877200 | Weak transcription | Fetal Intestine Small | intestine |
2 | chr16:74870600-74877000 | Weak transcription | Esophagus | oesophagus |
3 | chr16:74871400-74876000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr16:74871600-74875800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr16:74871600-74875800 | Weak transcription | NHEK | skin |
6 | chr16:74871600-74876000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
7 | chr16:74871600-74876000 | Weak transcription | HMEC | breast |
8 | chr16:74872600-74877000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
9 | chr16:74872800-74877600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
10 | chr16:74873400-74875200 | Weak transcription | Placenta | Placenta |
11 | chr16:74875200-74875400 | Enhancers | Placenta | Placenta |
12 | chr16:74875400-74875800 | Weak transcription | Placenta | Placenta |
13 | chr16:74875800-74876200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
14 | chr16:74875800-74877000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
15 | chr16:74875800-74877000 | Enhancers | Dnd41 | blood |
16 | chr16:74875800-74878400 | Enhancers | NHEK | skin |
17 | chr16:74875800-74879400 | Enhancers | Placenta | Placenta |